CINXE.COM
HL7 SPL Submission Option
<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml"> <head><title> HL7 SPL Submission Option </title><link rel="icon" type="image/png" href="favicon.png" /><meta name="viewport" content="width=device-width, initial-scale=1.0" /> <style> :root{background-color:#000} html, body { width: 100vw; height: 100vh; margin: 0; padding: 0; } </style> <script> window.SiteData = { ApplicationRoot: '/Mediasite/Play', ApplicationScriptsRoot: '/Mediasite/Play/Dist', PlayerService: '/mediasite/PlayerService/PlayerService.svc/json', FileServer: 'https://fda.yorkcast.com/mediasite/FileServer', WebAppsApi: '/mediasite/MyMediasite/webapps-api', AntiForgeryToken: '_D-AeQMp4Jh4iYKkfgGLtDATWNzrc-Q81V5Qsl8QlC0f5dM7WG7-ncJHTTFkjBSD87h_urbi-gemivob81bW_YSuPlc1:YDdKKD0xl9UgHlQgN_51Gp4cZ1K8L-Js2SRy9zWV0U23pWt1QyTU0j-58VCW1nkMAo-PVJY0V3G2viqcjQy9zXyfHIQ1', AntiForgeryHeaderName: 'X-SOFO-AntiForgeryHeader', LocalizedDictionary: [], Culture: 'en-US', UserName: "", DisplayName: "", UserEmailAddress: "", FullStoryOptOut: false, AuthTicket: '', CollectionId: '', PresentationId: '2c41f519e6f34e28b2c784795e5ab57a1d', SystemFont: 'Default', VersionNumber: "8.35.0", IsSiteEnvironmentHosting: true, } document.documentElement.setAttribute("lang", 'en-US'); </script> <script defer src="Dist/player-page/runtime.268e58615dfee18eb309.js"></script> <script defer src="Dist/player-page/vendor.9f553175754904a3ebb5.js"></script> <script defer src="Dist/player-page/main.d324ad682e7419ad8981.js"></script> <script defer src="https://fda.yorkcast.com/mediasite/Manage/Areas/Shared/Content/plugins/SystemFont/SystemFont.js"></script> <meta property="og:type" content="article" /><meta property="og:title" content=" HL7 SPL Submission Option" /><meta property="og:url" content="https://fda.yorkcast.com/mediasite/Play/2c41f519e6f34e28b2c784795e5ab57a1d" /><meta property="og:image" content="https://fda.yorkcast.com/mediasite/FileServer/Presentation/2c41f519e6f34e28b2c784795e5ab57a1d/9ea322df-d455-4fa0-aa7e-fdc38312fc1e.jpg" /><meta property="og:image" content="https://fda.yorkcast.com/mediasite/FileServer/efe2ed9a79234401b73f2b0e71d0c92f29/Presentation/2c41f519e6f34e28b2c784795e5ab57a1d/slide_0001_248_186.jpg" /><meta property="og:description" content="In this presentation, Linda Sigg will start off with an overview of the GUDID HL7 SPL Submission Option, talk about the required testing that is necessary before you send Production GUDID submissions, examine the FDA Electronic Submissions Gateway or ESG, explain the three acknowledgements that you will receive and the purpose of each of them, share with you some helpful pointers on using the HL7 SPL submission option such as how to edit and manage your DI records and ho to use third party submitters, and provide information on whom to contact, and when, for help. " /><meta name="description" content="In this presentation, Linda Sigg will start off with an overview of the GUDID HL7 SPL Submission Option, talk about the required testing that is necessary before you send Production GUDID submissions, examine the FDA Electronic Submissions Gateway or ESG, explain the three acknowledgements that you will receive and the purpose of each of them, share with you some helpful pointers on using the HL7 SPL submission option such as how to edit and manage your DI records and ho to use third party submitters, and provide information on whom to contact, and when, for help. " /></head> <body> <div class="mediasite-standalone-player-container"> <video preload="auto" playsinline></video> </div> </body> </html>